Stay updated on TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page.

Latest updates to the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision updated to v3.4.3; the previous revision v3.4.2 is no longer listed.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded Gastric cancer topic and a new external resource link to the Genetic and Rare Diseases Information Center. Page revision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check32 days agoChange DetectedA full citation for the TAGS trial (Lancet Oncol. 2018) was added to Publications, and the record version was updated from v3.4.0 (with an erratum) to v3.4.1.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded a 'Show glossary' toggle and updated the Revision label to v3.4.0. Minor wording changes to QC criteria status and FEAR Act data appear in the metadata.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed.SummaryDifference0.0%

- Check61 days agoChange DetectedThe Publications section was updated to replace the TAGS Lancet Oncol 2018 paper citation with the version that includes the erratum. The prior non-erratum citation was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page.